ANGIOTENSIN CONVERTING ENZYME-INHIBITION IN TISSUES FROM SPONTANEOUSLY HYPERTENSIVE RATS AFTER TREATMENT WITH CAPTOPRIL OR MK-421
- 1 January 1982
- journal article
- research article
- Vol. 220 (1), 63-69
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- ANTIHYPERTENSIVE ACTIVITY OF N-[(S)-1-(ETHOXYCARBONYL)-3-PHENYLPROPYL]-L-ALA-L-PRO (MK-421), AN ORALLY ACTIVE CONVERTING ENZYME-INHIBITOR1981
- EFFECT OF N-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-ALA-L-PRO AND ITS ETHYL-ESTER (MK-421) ON ANGIOTENSIN CONVERTING ENZYME INVITRO AND ANGIOTENSIN-I PRESSOR-RESPONSES INVIVO1981
- Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brainEuropean Journal of Pharmacology, 1980
- Angiotensin-1-Converting Enzyme Activity in the Spontaneously Hypertensive RatExperimental Biology and Medicine, 1980
- Plasma converting enzyme activity (C.E.A.) : An index of plasma levels of captopril?Life Sciences, 1980
- Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.Hypertension, 1980
- Effects of an Orally Active Converting-Enzyme Inhibitor, SQ 14225, on Pressor Responses to Angiotensin Administered into the Brain Ventricles of Spontaneously Hypertensive RatsClinical Science, 1979
- Arterial Wall Renin and Renal Venous Renin in the Hypertensive RatClinical Science, 1979
- Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized catsEuropean Journal of Pharmacology, 1977
- Kinetic properties of pulmonary angiotensin-converting enzyme. Hydrolysis of hippurylglycylglycineBiochimica et Biophysica Acta (BBA) - Enzymology, 1976